Search Results for: Schizophrenia

1632 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
DPYD and GOPC dihydropyrimidine dehydrogenase golgi-associated PDZ and coiled-coil motif containing
  • Pyrimidine catabolism
  • Pyrimidine metabolism
  • Metabolism of nucleotides
  • (5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione
  • Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate
  • 6-Carboxymethyluracil
  • Flavin-Adenine Dinucleotide
  • Riboflavin Monophosphate
  • Uracil
  • 5-Iodouracil
DPYD and LXN dihydropyrimidine dehydrogenase latexin
  • Pyrimidine catabolism
  • Pyrimidine metabolism
  • Metabolism of nucleotides
  • (5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione
  • Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate
  • 6-Carboxymethyluracil
  • Flavin-Adenine Dinucleotide
  • Riboflavin Monophosphate
  • Uracil
  • 5-Iodouracil
GRIN2A and PLCG1 glutamate receptor, ionotropic, N-methyl D-aspartate 2A phospholipase C, gamma 1
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • CREB phosphorylation through the activation of CaMKII
  • CREB phosphorylation through the activation of Ras
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Unblocking of NMDA receptor, glutamate binding and activation
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Post NMDA receptor activation events
  • Transmission across Chemical Synapses
  • Signaling by the B Cell Receptor (BCR)
  • Phospholipase C-mediated cascade
  • Signaling by FGFR in disease
  • FCERI mediated MAPK activation
  • Signaling by EGFRvIII in Cancer
  • PLCG1 events in ERBB2 signaling
  • DAP12 signaling
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Synthesis of IP3 and IP4 in the cytosol
  • Signaling by FGFR1 mutants
  • Role of phospholipids in phagocytosis
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Signaling by PDGF
  • DAP12 interactions
  • Inositol phosphate metabolism
  • Antiviral mechanism by IFN-stimulated genes
  • EGFR interacts with phospholipase C-gamma
  • Signaling by ERBB2
  • Signaling by EGFR
  • TCR signaling
  • Signaling by VEGF
  • Downstream signal transduction
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Signaling by FGFR mutants
  • Frs2-mediated activation
  • Adaptive Immune System
  • Signalling to ERKs
  • Prolonged ERK activation events
  • Axon guidance
  • DAG and IP3 signaling
  • VEGFA-VEGFR2 Pathway
  • VEGFR2 mediated cell proliferation
  • Downstream signaling of activated FGFR
  • Netrin-1 signaling
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Innate Immune System
  • Signalling by NGF
  • Generation of second messenger molecules
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Signaling by FGFR
  • PECAM1 interactions
  • Cell surface interactions at the vascular wall
  • Role of second messengers in netrin-1 signaling
  • PLC-gamma1 signalling
  • FCERI mediated Ca+2 mobilization
  • Constitutive Signaling by EGFRvIII
  • Signaling by FGFR1 fusion mutants
  • L-Glutamic Acid
  • Glycine
  • Meperidine
  • Felbamate
  • Memantine
  • Halothane
  • Tenocyclidine
GRIN2A and AP1M1 glutamate receptor, ionotropic, N-methyl D-aspartate 2A adaptor-related protein complex 1, mu 1 subunit
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • CREB phosphorylation through the activation of CaMKII
  • CREB phosphorylation through the activation of Ras
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Unblocking of NMDA receptor, glutamate binding and activation
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Post NMDA receptor activation events
  • Transmission across Chemical Synapses
  • Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
  • HIV Infection
  • Host Interactions of HIV factors
  • Golgi Associated Vesicle Biogenesis
  • The role of Nef in HIV-1 replication and disease pathogenesis
  • Nef mediated downregulation of MHC class I complex cell surface expression
  • Clathrin derived vesicle budding
  • Lysosome Vesicle Biogenesis
  • MHC class II antigen presentation
  • trans-Golgi Network Vesicle Budding
  • Adaptive Immune System
  • L-Glutamic Acid
  • Glycine
  • Meperidine
  • Felbamate
  • Memantine
  • Halothane
  • Tenocyclidine
GRIN2A and DLGAP1 glutamate receptor, ionotropic, N-methyl D-aspartate 2A discs, large (Drosophila) homolog-associated protein 1
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • CREB phosphorylation through the activation of CaMKII
  • CREB phosphorylation through the activation of Ras
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Unblocking of NMDA receptor, glutamate binding and activation
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Post NMDA receptor activation events
  • Transmission across Chemical Synapses
  • L-Glutamic Acid
  • Glycine
  • Meperidine
  • Felbamate
  • Memantine
  • Halothane
  • Tenocyclidine
GRIN2A and RGS3 glutamate receptor, ionotropic, N-methyl D-aspartate 2A regulator of G-protein signaling 3
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • CREB phosphorylation through the activation of CaMKII
  • CREB phosphorylation through the activation of Ras
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Unblocking of NMDA receptor, glutamate binding and activation
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Post NMDA receptor activation events
  • Transmission across Chemical Synapses
  • L-Glutamic Acid
  • Glycine
  • Meperidine
  • Felbamate
  • Memantine
  • Halothane
  • Tenocyclidine
GRIN2A and IL16 glutamate receptor, ionotropic, N-methyl D-aspartate 2A interleukin 16
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • CREB phosphorylation through the activation of CaMKII
  • CREB phosphorylation through the activation of Ras
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Unblocking of NMDA receptor, glutamate binding and activation
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Post NMDA receptor activation events
  • Transmission across Chemical Synapses
  • L-Glutamic Acid
  • Glycine
  • Meperidine
  • Felbamate
  • Memantine
  • Halothane
  • Tenocyclidine
GRIN2A and SPTAN1 glutamate receptor, ionotropic, N-methyl D-aspartate 2A spectrin, alpha, non-erythrocytic 1
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • CREB phosphorylation through the activation of CaMKII
  • CREB phosphorylation through the activation of Ras
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Unblocking of NMDA receptor, glutamate binding and activation
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Post NMDA receptor activation events
  • Transmission across Chemical Synapses
  • Interaction between L1 and Ankyrins
  • Apoptotic cleavage of cellular proteins
  • Axon guidance
  • Programmed Cell Death
  • Apoptotic execution phase
  • Nephrin interactions
  • L1CAM interactions
  • Caspase-mediated cleavage of cytoskeletal proteins
  • NCAM signaling for neurite out-growth
  • L-Glutamic Acid
  • Glycine
  • Meperidine
  • Felbamate
  • Memantine
  • Halothane
  • Tenocyclidine
GRIN2A and ARHGAP32 glutamate receptor, ionotropic, N-methyl D-aspartate 2A Rho GTPase activating protein 32
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • CREB phosphorylation through the activation of CaMKII
  • CREB phosphorylation through the activation of Ras
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Unblocking of NMDA receptor, glutamate binding and activation
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Post NMDA receptor activation events
  • Transmission across Chemical Synapses
  • Rho GTPase cycle
  • Signaling by Rho GTPases
  • L-Glutamic Acid
  • Glycine
  • Meperidine
  • Felbamate
  • Memantine
  • Halothane
  • Tenocyclidine
GRIN2A and AP4M1 glutamate receptor, ionotropic, N-methyl D-aspartate 2A adaptor-related protein complex 4, mu 1 subunit
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • CREB phosphorylation through the activation of CaMKII
  • CREB phosphorylation through the activation of Ras
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Unblocking of NMDA receptor, glutamate binding and activation
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Post NMDA receptor activation events
  • Transmission across Chemical Synapses
  • L-Glutamic Acid
  • Glycine
  • Meperidine
  • Felbamate
  • Memantine
  • Halothane
  • Tenocyclidine
GRIN2A and CASK glutamate receptor, ionotropic, N-methyl D-aspartate 2A calcium/calmodulin-dependent serine protein kinase (MAGUK family)
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • CREB phosphorylation through the activation of CaMKII
  • CREB phosphorylation through the activation of Ras
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Unblocking of NMDA receptor, glutamate binding and activation
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Post NMDA receptor activation events
  • Transmission across Chemical Synapses
  • Syndecan interactions
  • Nephrin interactions
  • Non-integrin membrane-ECM interactions
  • L-Glutamic Acid
  • Glycine
  • Meperidine
  • Felbamate
  • Memantine
  • Halothane
  • Tenocyclidine
GRIN2A and NEDD4 glutamate receptor, ionotropic, N-methyl D-aspartate 2A neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • CREB phosphorylation through the activation of CaMKII
  • CREB phosphorylation through the activation of Ras
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Unblocking of NMDA receptor, glutamate binding and activation
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Post NMDA receptor activation events
  • Transmission across Chemical Synapses
  • Downregulation of ERBB4 signaling
  • Antigen processing: Ubiquitination & Proteasome degradation
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Class I MHC mediated antigen processing & presentation
  • Signaling by ERBB4
  • Antiviral mechanism by IFN-stimulated genes
  • Adaptive Immune System
  • L-Glutamic Acid
  • Glycine
  • Meperidine
  • Felbamate
  • Memantine
  • Halothane
  • Tenocyclidine
GRIN2A and INADL glutamate receptor, ionotropic, N-methyl D-aspartate 2A InaD-like (Drosophila)
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • CREB phosphorylation through the activation of CaMKII
  • CREB phosphorylation through the activation of Ras
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Unblocking of NMDA receptor, glutamate binding and activation
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Post NMDA receptor activation events
  • Transmission across Chemical Synapses
  • Cell junction organization
  • Cell-cell junction organization
  • Tight junction interactions
  • L-Glutamic Acid
  • Glycine
  • Meperidine
  • Felbamate
  • Memantine
  • Halothane
  • Tenocyclidine
GSTA1 and ST3GAL1 glutathione S-transferase alpha 1 ST3 beta-galactoside alpha-2,3-sialyltransferase 1
  • Defective OPLAH causes 5-oxoprolinase deficiency (OPLAHD)
  • Defective AHCY causes Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD)
  • Defective TPMT causes Thiopurine S-methyltransferase deficiency (TPMT deficiency)
  • Defective MAT1A causes Methionine adenosyltransferase deficiency (MATD)
  • Defective UGT1A4 causes hyperbilirubinemia
  • Glutathione conjugation
  • Metabolic disorders of biological oxidation enzymes
  • Phase II conjugation
  • Defective UGT1A1 causes hyperbilirubinemia
  • Defective SLC35D1 causes Schneckenbecken dysplasia (SCHBCKD)
  • Biological oxidations
  • Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD)
  • Defective GGT1 causes Glutathionuria (GLUTH)
  • Defective GSS causes Glutathione synthetase deficiency (GSS deficiency)
  • Keratan sulfate/keratin metabolism
  • MPS I - Hurler syndrome
  • MPS IX - Natowicz syndrome
  • Glycosaminoglycan metabolism
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • O-linked glycosylation
  • Defective CHST14 causes EDS, musculocontractural type
  • Myoclonic epilepsy of Lafora
  • MPS IIID - Sanfilippo syndrome D
  • Defective CHST6 causes MCDC1
  • Glycogen storage diseases
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Keratan sulfate biosynthesis
  • Diseases associated with glycosaminoglycan metabolism
  • Mucopolysaccharidoses
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Post-translational protein modification
  • Defective EXT2 causes exostoses 2
  • Termination of O-glycan biosynthesis
  • Synthesis of substrates in N-glycan biosythesis
  • Asparagine N-linked glycosylation
  • MPS IV - Morquio syndrome A
  • Sialic acid metabolism
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Metabolism of carbohydrates
  • O-linked glycosylation of mucins
  • Diseases associated with N-glycosylation of proteins
  • MPS VI - Maroteaux-Lamy syndrome
  • MPS IIIB - Sanfilippo syndrome B
  • Diseases of glycosylation
  • Defective B4GALT7 causes EDS, progeroid type
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective SLC26A2 causes chondrodysplasias
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective PAPSS2 causes SEMD-PA
  • Defective MAN1B1 causes MRT15
  • MPS IIIA - Sanfilippo syndrome A
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • MPS IIIC - Sanfilippo syndrome C
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • MPS II - Hunter syndrome
  • Defective CHST3 causes SEDCJD
  • Defective B3GAT3 causes JDSSDHD
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Defective EXT1 causes exostoses 1, TRPS2 and CHDS
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective CHSY1 causes TPBS
  • MPS IV - Morquio syndrome B
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • MPS VII - Sly syndrome
  • Glutathione
  • S-Hydroxycysteine
  • 2-Hydroxyethyl Disulfide
  • N-(4-Aminobutanoyl)-S-(4-Methoxybenzyl)-L-Cysteinylglycine
  • Glutathione Sulfonic Acid
  • S-Benzyl-Glutathione
  • S-Hexylglutathione
KCNJ11 and KCNJ2 potassium channel, inwardly rectifying subfamily J, member 11 potassium channel, inwardly rectifying subfamily J, member 2
  • Inwardly rectifying K+ channels
  • Integration of energy metabolism
  • ATP sensitive Potassium channels
  • Regulation of insulin secretion
  • Potassium Channels
  • GABA B receptor activation
  • Inwardly rectifying K+ channels
  • GABA receptor activation
  • Activation of G protein gated Potassium channels
  • Classical Kir channels
  • Activation of GABAB receptors
  • Potassium Channels
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • G protein gated Potassium channels
  • Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
  • Transmission across Chemical Synapses
  • Glimepiride
  • Ibutilide
  • Verapamil
  • Levosimendan
  • Glyburide
  • Diazoxide
  • Thiamylal
TOP1 and PPP2R2B topoisomerase (DNA) I protein phosphatase 2, regulatory subunit B, beta
  • Irinotecan
  • Topotecan
  • Camptothecin
  • Lucanthone
  • Sodium stibogluconate
  • 2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM
  • 4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE
RARA and HDAC4 retinoic acid receptor, alpha histone deacetylase 4
  • Generic Transcription Pathway
  • Signaling by Retinoic Acid
  • Nuclear Receptor transcription pathway
  • Orphan transporters
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Signaling by NOTCH
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by NOTCH1
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • FBXW7 Mutants and NOTCH1 in Cancer
  • Adapalene
  • Acitretin
  • Alitretinoin
  • Tazarotene
  • Etretinate
  • Isotretinoin
  • Tamibarotene
RARA and PHF8 retinoic acid receptor, alpha PHD finger protein 8
  • Generic Transcription Pathway
  • Signaling by Retinoic Acid
  • Nuclear Receptor transcription pathway
  • Orphan transporters
  • Chromatin modifying enzymes
  • Chromatin organization
  • HDMs demethylate histones
  • Adapalene
  • Acitretin
  • Alitretinoin
  • Tazarotene
  • Etretinate
  • Isotretinoin
  • Tamibarotene
TUBB and DISC1 tubulin, beta class I disrupted in schizophrenia 1
  • Organelle biogenesis and maintenance
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Loss of Nlp from mitotic centrosomes
  • G2/M Transition
  • Assembly of the primary cilium
  • Centrosome maturation
  • Regulation of PLK1 Activity at G2/M Transition
  • Mitotic G2-G2/M phases
  • Anchoring of the basal body to the plasma membrane
  • Recruitment of mitotic centrosome proteins and complexes
  • Cell Cycle, Mitotic
  • Vinorelbine
  • Vincristine
  • Vinblastine
  • Podofilox
  • Colchicine
  • Epothilone D
  • Epothilone B
CDK1 and IL3RA cyclin-dependent kinase 1 interleukin 3 receptor, alpha (low affinity)
  • Phosphorylation of the APC/C
  • Signaling by FGFR in disease
  • Phosphorylation of Emi1
  • Signaling by EGFRvIII in Cancer
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Toll Like Receptor 5 (TLR5) Cascade
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • MyD88 dependent cascade initiated on endosome
  • SOS-mediated signalling
  • Mitotic G1-G1/S phases
  • SHC-mediated signalling
  • Recruitment of mitotic centrosome proteins and complexes
  • TRIF-mediated TLR3/TLR4 signaling
  • ERK1 activation
  • Nuclear Pore Complex (NPC) Disassembly
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • Regulation of APC/C activators between G1/S and early anaphase
  • ERK1 activation
  • APC/C:Cdc20 mediated degradation of Cyclin B
  • Signaling by VEGF
  • Resolution of Sister Chromatid Cohesion
  • Downstream signal transduction
  • Signalling to RAS
  • Toll Like Receptor 3 (TLR3) Cascade
  • Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
  • APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
  • Interleukin-2 signaling
  • Mitotic G2-G2/M phases
  • Frs2-mediated activation
  • MASTL Facilitates Mitotic Progression
  • Axon guidance
  • IRS-mediated signalling
  • G2/M Transition
  • VEGFA-VEGFR2 Pathway
  • Activated TLR4 signalling
  • VEGFR2 mediated cell proliferation
  • GRB2 events in ERBB2 signaling
  • Cyclin A/B1 associated events during G2/M transition
  • Loss of Nlp from mitotic centrosomes
  • MyD88:Mal cascade initiated on plasma membrane
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • NCAM signaling for neurite out-growth
  • RAF/MAP kinase cascade
  • Signalling to p38 via RIT and RIN
  • Innate Immune System
  • Condensation of Prometaphase Chromosomes
  • Signaling by Insulin receptor
  • E2F mediated regulation of DNA replication
  • Insulin receptor signalling cascade
  • Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes
  • G0 and Early G1
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • IRS-related events
  • SHC-related events
  • Signaling by FGFR
  • ARMS-mediated activation
  • Toll-Like Receptors Cascades
  • Toll Like Receptor 10 (TLR10) Cascade
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • E2F-enabled inhibition of pre-replication complex formation
  • Regulation of mitotic cell cycle
  • Cell Cycle Checkpoints
  • Signaling by GPCR
  • G2/M Checkpoints
  • Mitotic Prophase
  • Golgi Cisternae Pericentriolar Stack Reorganization
  • FCERI mediated MAPK activation
  • Regulation of PLK1 Activity at G2/M Transition
  • SHC1 events in ERBB2 signaling
  • Signaling by SCF-KIT
  • DAP12 signaling
  • G1/S Transition
  • G1/S-Specific Transcription
  • Toll Like Receptor 9 (TLR9) Cascade
  • G2/M DNA replication checkpoint
  • Signaling by PDGF
  • DAP12 interactions
  • SHC-related events triggered by IGF1R
  • GRB2 events in EGFR signaling
  • Signaling by ERBB4
  • APC/C-mediated degradation of cell cycle proteins
  • Toll Like Receptor 2 (TLR2) Cascade
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by Interleukins
  • SHC1 events in ERBB4 signaling
  • Toll Like Receptor 4 (TLR4) Cascade
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Condensation of Prophase Chromosomes
  • Signaling by Leptin
  • Signalling to ERKs
  • Mitotic Prometaphase
  • Prolonged ERK activation events
  • Organelle biogenesis and maintenance
  • ERK activation
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Activation of NIMA Kinases NEK9, NEK6, NEK7
  • Nuclear Envelope Breakdown
  • IGF1R signaling cascade
  • Recruitment of NuMA to mitotic centrosomes
  • Cyclin B2 mediated events
  • Toll Like Receptor TLR6:TLR2 Cascade
  • M Phase
  • IRS-related events triggered by IGF1R
  • MyD88 cascade initiated on plasma membrane
  • ERK activation
  • Downstream signaling of activated FGFR
  • Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
  • Signalling by NGF
  • SOS-mediated signalling
  • G2/M DNA damage checkpoint
  • MAP kinase activation in TLR cascade
  • SHC-mediated signalling
  • Depolymerisation of the Nuclear Lamina
  • Assembly of the primary cilium
  • Cytokine Signaling in Immune system
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • MyD88-independent cascade
  • Anchoring of the basal body to the plasma membrane
  • Cell Cycle, Mitotic
  • SHC1 events in EGFR signaling
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • FRS2-mediated cascade
  • IRS-mediated signalling
  • Centrosome maturation
  • Signaling by GPCR
  • G-protein beta:gamma signalling
  • Cytokine Signaling in Immune system
  • GPCR downstream signaling
  • Signaling by Interleukins
  • Interleukin receptor SHC signaling
  • G beta:gamma signalling through PI3Kgamma
  • Interleukin receptor SHC signaling
  • GPVI-mediated activation cascade
  • Interleukin-2 signaling
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Indirubin-3\'-Monoxime
  • Olomoucine
  • Hymenialdisine
  • SU9516
  • Flavopiridol
  • Alsterpaullone
  • Sargramostim

Page 6 out of 82 pages